Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-019743

Pres and CEO bought 6,300 shares at $7.86 ($49,532)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manion Douglas J. Pres and CEO 2023-03-17 Purchase +6,300 $7.86 $49,532 12,800 D
Open-market purchases · 6,300 sh · avg $7.86 · $49,532
Loading xslF345X03/doc4.xml…